SKI Market

Indian Indices

Sensex

82,225.92 -1,068.74
( -1.28%)

Global Indices

Nasdaq

48,816.07 -830.91
(-1.67%)

Dow Jones

6,858.07 -72.44
(-1.05%)

Hang Seng

57,337.44 511.74
(0.90%)

Nikkei 225

10,686.70 1.96
(0.02%)

Forex

USD-INR

90.72 -0.31
(-0.34%)

EUR-INR

106.89 -0.33
(-0.31%)

GBP-INR

122.26 -0.41
(-0.34%)

JPY-INR

0.59 0.00
(-0.41%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Glaxosmithkline Pharmaceuticals Ltd

Industry : Pharmaceuticals - Multinational

BSE Code

ISIN Demat

Book Value()

500660

INE159A01016

100.5174369

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

GLAXO

44.9

44678.3

EPS(TTM)

Face Value()

Div & Yield %

58.74

2.05

Back

Salem Erode Investments Ltd - Board Meeting Outcome for Outcome Of Board Meeting Held On September 23 2025

Sep 23,2025

Considered and approved issue of 7500 (Seven Thousand Five Hundred Only) Unlisted Secured Redeemable Non-Convertible Debentures of face value of Rs. 1000/- (Rupees One Thousand Only) each for cash at par aggregating to Rs. 7500000/- (Rupees Seventy Five Lakhs only) on private placement basis

82,225.92 -1,068.74 ( -1.28%)

48,816.07 -830.91 (-1.67%)

6,858.07 -72.44 (-1.05%)

57,337.44 511.74 (0.90%)

10,686.70 1.96 (0.02%)

90.72 -0.31 (-0.34%)

106.89 -0.33 (-0.31%)

122.26 -0.41 (-0.34%)

0.59 0.00 (-0.41%)